Zomedica Pharmaceuticals (ZOM)
US Market

Zomedica Pharmaceuticals (ZOM) Financial Statements


Zomedica Pharmaceuticals Financial Overview

Zomedica Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.038; its P/E ratio is -3.96; Zomedica Pharmaceuticals is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 7.34M$ 6.35M$ 6.02M$ 5.48M$ 6.16M
Gross Profit$ 5.07M$ 4.36M$ 6.02M$ 3.83M$ 4.29M
EBIT$ -21.95M$ -2.35M$ -5.26M$ -7.54M$ -3.75M
EBITDA$ -20.08M-$ -3.79M$ -6.18M$ -2.93M
Net Income Common Stockholders$ -22.41M$ -491.00K$ -5.25M$ -6.38M$ -2.81M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 90.50M$ 106.21M$ 130.47M$ 8.35M$ 27.40M
Total Assets$ 253.20M$ 275.05M$ 274.78M$ 279.60M$ 279.61M
Total Debt$ 2.73M$ 1.75M$ 1.42M$ 140.69M$ 130.14M
Net Debt$ -87.77M$ -104.45M$ -129.05M$ 132.34M$ 102.74M
Total Liabilities$ 13.18M$ 14.17M$ 15.30M$ 16.54M$ 12.22M
Stockholders Equity$ 240.02M$ 260.88M$ 259.48M$ 263.06M$ 267.39M
Cash Flow-
Free Cash Flow$ -7.08M-$ -5.61M$ -9.23M$ -3.17M
Operating Cash Flow$ -5.01M$ -3.03M$ -3.68M$ -4.26M$ -2.38M
Investing Cash Flow$ -3.83M$ -3.12M$ 23.32M$ -14.79M$ -15.35M
Financing Cash Flow-----
Currency in USD

Zomedica Pharmaceuticals Earnings and Revenue History

Zomedica Pharmaceuticals Debt to Assets

Zomedica Pharmaceuticals Cash Flow

Zomedica Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis